In contrast, we found that IDH1nonR132H mutations were more frequent in astrocytic (6/60, 10.0% IDH mutated tumors) and mixed tumors (15/176, 8.5%), compared to oligodendroglial tumors (15/332, 4.5%, P = 0.037). This evidence concerns the gene IDH1 and oligodendroglial tumor.